95 related articles for article (PubMed ID: 3513319)
1. A randomized comparative study of prednimustine and doxorubicin in patients with metastatic breast cancer.
Allegra JC
Semin Oncol; 1986 Mar; 13(1 Suppl 1):42-4. PubMed ID: 3513319
[TBL] [Abstract][Full Text] [Related]
2. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
[TBL] [Abstract][Full Text] [Related]
3. A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
Rørth M; Løber J; Dombernowsky P; Krusenstjerna-Hofstrom D; Mattsson W; Mouridsen HT
Eur J Cancer (1965); 1980; Suppl 1():137-40. PubMed ID: 7032923
[No Abstract] [Full Text] [Related]
4. Prednimustine in advanced breast cancer: a review.
Mouridsen HT
Semin Oncol; 1986 Mar; 13(1 Suppl 1):27-31. PubMed ID: 3513318
[TBL] [Abstract][Full Text] [Related]
5. Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma.
Leonard RC; Smart GE; Livingstone JR; Cornbleet MA; Kerr GR; Fletcher S; Webb JN; Smyth JF
Cancer Chemother Pharmacol; 1989; 23(2):105-10. PubMed ID: 2491962
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancer.
Rankin EM; Harvey C; Knight RK; Rubens RD
Cancer Treat Rep; 1987 Nov; 71(11):1107-8. PubMed ID: 3119205
[No Abstract] [Full Text] [Related]
7. Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer.
Mouridsen HT; Kristensen D; Nielsen JH; Dombernowsky P
Cancer; 1980 Jul; 46(2):253-5. PubMed ID: 7388770
[TBL] [Abstract][Full Text] [Related]
8. Premarin priming before prednimustine, high-dose folinic acid and 5-fluorouracil as salvage chemotherapy for advanced breast cancer.
Marini G; Simoncini E; Marpicati P; Montini E; Ferrari V; Arcangeli G; Zaniboni A
Chemioterapia; 1988 Apr; 7(2):130-2. PubMed ID: 2840216
[TBL] [Abstract][Full Text] [Related]
9. Value of prednimustine in treating non Hodgkin's lymphomas of favourable histological type.
Klener P; Háber J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):103-8. PubMed ID: 2581855
[TBL] [Abstract][Full Text] [Related]
10. Prednimustine treatment in malignant lymphomas.
Szántó I; Fleischmann T; Eckhardt S
Oncology; 1989; 46(4):205-7. PubMed ID: 2662086
[TBL] [Abstract][Full Text] [Related]
11. The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation.
Murphy GP; Gibbons RP; Johnson DE; Prout GR; Schmidt JD; Soloway MS; Loening SA; Chu TM; Gaeta JF; Saroff J; Wajsman Z; Slack N; Scott WW
J Urol; 1979 Jun; 121(6):763-5. PubMed ID: 458947
[TBL] [Abstract][Full Text] [Related]
12. Prednimustine in adult acute myeloid leukaemia.
Brandt L; Könyves I
Cancer Chemother Pharmacol; 1979; 2(2):133-6. PubMed ID: 394873
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics of chlorambucil and prednimustine after oral administration.
Loos U; Musch E; Malek M; Riedel E
Oncology; 1991; 48(4):334-42. PubMed ID: 1891177
[TBL] [Abstract][Full Text] [Related]
14. The antitumor effect of prednimustine in vitro and in vivo.
Hartley-Asp B
Semin Oncol; 1986 Mar; 13(1 Suppl 1):3-7. PubMed ID: 3952519
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of Prednimustine. Leo-1031 (NSC-134087) in acute non-lymphocytic leukemia.
Juul K; Sørensen P; Pedersen-Bjergaard J; Jensen MK
Scand J Haematol; 1979 Nov; 23(5):388-92. PubMed ID: 396664
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroids and alkylating agents.
Pedersen-Bjergaard J; Hansen MM; Geisler CH; Nissen NI
Acta Med Scand; 1980; 207(3):215-20. PubMed ID: 6989170
[TBL] [Abstract][Full Text] [Related]
17. Prednimustine: the rationale for clinical development.
Schein PS; Cavalli F
Semin Oncol; 1986 Mar; 13(1 Suppl 1):1-2. PubMed ID: 3952515
[No Abstract] [Full Text] [Related]
18. Prednimustine.
Semin Oncol; 1986 Mar; 13(1 Suppl 1):1-44. PubMed ID: 3952516
[No Abstract] [Full Text] [Related]
19. [A phase II study of prednimustine in advanced ovarian cancer].
Grundsell H; Johnsson JE; Tropé C
Lakartidningen; 1980 Sep; 77(39):3394-7. PubMed ID: 6161283
[No Abstract] [Full Text] [Related]
20. Prednisolone plasma levels after oral administration of Prednimustine. Comparison with levels obtained after administration of an equimolar dose of prednisolone.
Sayed A; Hove WV; Vermeulen A
Oncology; 1981; 38(6):351-5. PubMed ID: 7301281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
